BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Petar Jolakoski

Petar Jolakoski appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
econ.GNq-fin.ECApplicationscond-mat.stat-mechphysics.soc-ph

Catalog footprint

What is connected

3works
5topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Correlates of the country differences in the infection and mortality rates during the first wave of the COVID-19 pandemic: Evidence from Bayesian model averaging

In the initial wave of the COVID-19 pandemic we observed great discrepancies in both infection and mortality rates between countries. Besides the biological and epidemiological factors, a multitude of social and economic criteria also influence the extent to which these discrepancies appear. Consequently, there is an active debate regarding the critical socio-economic and health factors that correlate with the infection and mortality rates outcome of the pandemic. Here, we leverage Bayesian model averaging techniques and country level data to investigate the potential of 28 variables, describing a diverse set of health and socio-economic characteristics, in being correlates of the final number of infections and deaths during the first wave of the coronavirus pandemic. We show that only few variables are able to robustly correlate with these outcomes. To understand the relationship between the potential correlates in explaining the infection and death rates, we create a Jointness Space. Using this space, we conclude that the extent to which each variable is able to provide a credible explanation for the COVID-19 infections/mortality outcome varies between countries because of their heterogeneous features.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Income inequality and mobility in geometric Brownian motion with stochastic resetting: theoretical results and empirical evidence of non-ergodicity

We explore the role of non-ergodicity in the relationship between income inequality, the extent of concentration in the income distribution, and mobility, the feasibility of an individual to change their position in the income distribution. For this purpose, we explore the properties of an established model for income growth that includes "resetting" as a stabilising force which ensures stationary dynamics. We find that the dynamics of inequality is regime-dependent and may range from a strictly non-ergodic state where this phenomenon has an increasing trend, up to a stable regime where inequality is steady and the system efficiently mimics ergodic behaviour. Mobility measures, conversely, are always stable over time, but the stationary value is dependent on the regime, suggesting that economies become less mobile in non-ergodic regimes. By fitting the model to empirical data for the dynamics of income share of the top earners in the United States, we provide evidence that the income dynamics in this country is consistently in a regime in which non-ergodicity characterises inequality and immobility dynamics. Our results can serve as a simple rationale for the observed real world income dynamics and as such aid in addressing non-ergodicity in various empirical settings across the globe.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

The impact of state capacity on the cross-country variations in COVID-19 vaccination rates

The initial period of vaccination shows strong heterogeneity between countries' vaccinations rollout, both in the terms of the start of the vaccination process and in the dynamics of the number of people that are vaccinated. A predominant thesis in the ongoing debate on the drivers of this observed heterogeneity is that a key determinant of the swift and extensive vaccine rollout is state capacity. Here, we utilize two measures that quantify different aspects of the state capacity: i) the external capacity (measured through the soft power and the economic power of the country) and ii) the internal capacity (measured via the country's government effectiveness) and investigate their relationship with the coronavirus vaccination outcome in the initial period (up to 30th January 2021). By using data on 189 countries and a two-step Heckman approach, we find that the economic power of the country and its soft power are robust determinants of whether a country has started with the vaccination process. In addition, the government effectiveness is a key factor that determines vaccine roll-out. Altogether, our findings are in line with the hypothesis that state capacity determines the observed heterogeneity between countries in the initial period of COVID-19 vaccines rollout.

0 citations0 reviewsNo code linkedOpen access